Global Synthetic Biology Market to Reach US$ 62.0 Billion by 2032, Stimulated by Increasing Demand for Sustainable Solutions

August 21, 2023 | Healthcare

According to the latest report by IMARC Group, titled “Synthetic Biology Market Report by Product (Oligonucleotide/Oligo Pools and Synthetic DNA, Enzymes, Cloning Technologies Kits, Xeno-nucleic Acids, Chassis Organism), Technology (NGS Technology, PCR Technology, Genome Editing Technology, Bioprocessing Technology, and Others), Application (Healthcare, Non-Healthcare), and Region 2024-2032,” the global synthetic biology market size reached US$ 16.0 Billion in 2023. Synthetic biology refers to an interdisciplinary field that combines principles from biology, engineering, and computer science to design and construct new biological parts, devices, and systems. It aims to engineer living organisms or create artificial biological systems with specific functions. Synthetic biologists utilize advanced techniques, such as gene synthesis, genetic engineering, and genome editing to manipulate the genetic code of organisms and create novel biological functionalities. The applications of synthetic biology are vast and diverse, ranging from the development of sustainable biofuels, bio-based materials, and pharmaceuticals to the creation of genetically modified organisms for environmental remediation and disease treatment. The field holds great promise in revolutionizing various industries and addressing complex global challenges, positioning it at the forefront of scientific research and innovation.

Global Synthetic Biology Market Trends:

The increasing demand for sustainable and environmentally friendly solutions is driving the global market. By leveraging genetic engineering techniques, synthetic biology offers the potential to create biodegradable materials, eco-friendly chemicals, and renewable energy sources, reducing the reliance on fossil fuels and mitigating the impact of human activities on the environment. Moreover, ongoing advancements in gene editing technologies have accelerated progress in synthetic biology since these powerful tools allow researchers to precisely edit the genetic code of organisms, enabling faster and more precise engineering of biological systems. Moreover, the growing interest and investment from both the public and private sectors have significantly contributed to the expansion of the synthetic biology market. Governments and companies recognize the immense potential of synthetic biology to drive innovation and economic growth and address critical challenges in healthcare, agriculture, and industrial production. Furthermore, the openness and accessibility of genetic data and biotechnological tools have enabled a broader community of researchers and entrepreneurs to participate in the synthetic biology ecosystem. Looking forward, the market value is projected to reach US$ 62.0 Billion by 2032, expanding at a CAGR of 15.9% during 2024-2032.       

Market Summary:

  • Based on the product, the market has been segmented into oligonucleotide/oligo pools and synthetic DNA, enzymes, cloning technologies kits, Xeno-nucleic acids, chassis organism.
  • On the basis of technology, the market has been divided into NGS, PCR, genome editing, bioprocessing, and other technologies.
  • Based on the application, the market has been bifurcated into healthcare (clinical, and non-clinical/research), and non-healthcare (biotech crops, specialty chemicals, bio-fuels, and others).
  • Region-wise, the market has been segmented into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa.
  • The competitive landscape of the market has also been examined, with some of the key players being Agilent Technologies Inc., Amyris Inc., Codexis Inc., Danaher Corporation, Eurofins Scientific, GenScript Biotech Corporation, Illumina Inc., Merck KGaA, New England Biolabs, Synthego Corporation, Thermo Fisher Scientific Inc., Twist Bioscience and Viridos Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Product, Technology, Application, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Agilent Technologies Inc., Amyris Inc., Codexis Inc., Danaher Corporation, Eurofins Scientific, GenScript Biotech Corporation, Illumina Inc., Merck KGaA, New England Biolabs, Synthego Corporation, Thermo Fisher Scientific Inc., Twist Bioscience and Viridos Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Synthetic Biology Market to Reach US$ 62.0 Billion by 2032, Stimulated by Increasing Demand for Sustainable Solutions
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More